kabutan

CellSource Co., Ltd.(4880) Summary

4880
TSE Prime
CellSource Co., Ltd.
378
JPY
+1
(+0.27%)
Mar 13, 3:30 pm JST
2.37
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
380.5
Mar 13, 8:09 pm JST
Summary Chart Historical News Financial Result
PER
PBR
1.27
Yield
ー%
Margin Trading Ratio
27.13
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
375 JPY 2.35 USD
Previous Close Mar 12
377 JPY 2.37 USD
High Mar 13, 9:33 am
382 JPY 2.40 USD
Low Mar 13, 9:00 am
371 JPY 2.33 USD
Volume
74,000
Trading Value
0.03B JPY 0.17M USD
VWAP
376.22 JPY 2.36 USD
Minimum Trading Value
37,800 JPY 237 USD
Market Cap
7.50B JPY 0.05B USD
Number of Trades
89
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Mid
1-Year Average
184
1-Year High May 28, 2025
954
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 292,200 570,100 1.95
Feb 27, 2026 222,000 550,100 2.48
Feb 20, 2026 216,500 534,800 2.47
Feb 13, 2026 173,600 501,400 2.89
Feb 6, 2026 178,100 518,000 2.91
Company Profile
CellSource Co., Ltd. develops and sells regenerative medicine-related products and cosmetics, specializing in cell processing from fat and blood.
Sector
Pharmaceuticals
CellSource Co., Ltd. primarily focuses on regenerative medicine-related businesses, providing cell processing and storage services from blood and fat for medical institutions. The company operates facilities licensed for manufacturing specific cell products under the Act on the Safety of Regenerative Medicine, where they extract, culture, and cryopreserve adipose-derived stem cells. Additionally, CellSource offers consulting services for regulatory compliance and management support necessary for providing regenerative medicine, as well as sales of related medical equipment. Furthermore, the company manufactures and sells its own cosmetics brand "Signalift," which incorporates proprietary ingredients derived from adipose stem cell research. CellSource also supplies cosmetic raw materials and provides OEM manufacturing services.